Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy

Autor: Dunne, Victoria, Ghita, Mihaela, Small, Donna M., Coffey, Caroline B.M., Weldon, Sinead, Taggart, Clifford C., Osman, Sarah O., McGarry, Conor K., Prise, Kevin M., Hanna, Gerard G., Butterworth, Karl T.
Zdroj: In Radiotherapy and Oncology September 2017 124(3):475-481
Databáze: ScienceDirect
Externí odkaz: